Comparative Pharmacology
Head-to-head clinical analysis: CARBOCAINE W NEO COBEFRIN versus RAVOCAINE AND NOVOCAIN W LEVOPHED.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CARBOCAINE W NEO COBEFRIN versus RAVOCAINE AND NOVOCAIN W LEVOPHED.
CARBOCAINE W/ NEO-COBEFRIN vs RAVOCAINE AND NOVOCAIN W/ LEVOPHED
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Mepivacaine is an amide-type local anesthetic that blocks sodium ion channels in nerve cell membranes, inhibiting nerve impulse conduction. Neo-cobefrin (levonordefrin) is a vasoconstrictor that acts on alpha-adrenergic receptors to constrict blood vessels, prolonging mepivacaine's action.
Stabilizes neuronal membranes by blocking sodium channels, inhibiting initiation and conduction of nerve impulses. Levophed (norepinephrine) is an alpha-adrenergic agonist causing vasoconstriction.
1-2% mepivacaine with 1:200,000 levonordefrin. Maximum dose: mepivacaine 400 mg (5 mg/kg); for dental infiltration: 0.5-1.8 mL, nerve block: 0.9-3.6 mL, epidural: 15-30 mL of 1% or 2% solution.
Dental infiltration: 1-2 mL of 2% lidocaine with 1:100,000 epinephrine (max 7 mg/kg or 500 mg total). For NOVOCAIN (procaine) with LEVOPHED (levonordefrin): 1-2 mL of 2% procaine with 1:20,000 levonordefrin, max 600 mg procaine per session.
None Documented
None Documented
Terminal elimination half-life ~2-3 hours; prolonged in hepatic impairment; clinical context: short duration of action
Procaine: terminal elimination half-life approximately 40 seconds (rapid plasma hydrolysis); levonordefrin: elimination half-life about 5-10 minutes, clinically brief vasoconstrictor effect.
Renal excretion of unchanged drug and metabolites; ~1-2% unchanged in urine; hepatic metabolism to inactive metabolites; biliary/fecal elimination minimal
Renal excretion of unchanged drug and metabolites: procaine <2% unchanged, >80% as para-aminobenzoic acid (PABA) and diethylaminoethanol (DEAE); levonordefrin (Levophed) undergoes hepatic metabolism and renal excretion of metabolites, <5% unchanged.
Category C
Category C
Local Anesthetic Combination
Local Anesthetic Combination